Compare Stocks: WAT, BRKR, RGEN, and TECH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BRKR Bruker	$54.76 -3.1%	$58.76	$32.37 ▼ $66.98	$8.34B	1.22	2.35 million shs	437,818 shs
RGEN Repligen	$174.95 -5.0%	$175.63	$100.99 ▼ $198.87	$9.87B	1.08	1.05 million shs	335,038 shs
TECH Bio-Techne	$72.48 -0.1%	$72.38	$43.19 ▼ $72.69	$11.37B	1.3	3.31 million shs	1.26 million shs
WAT Waters	$436.41 -1.7%	$420.24	$282.77 ▼ $454.54	$42.88B	1.15	959,935 shs	204,607 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BRKR Bruker	+1.69%	-2.38%	+1.42%	-2.90%	+56.19%
RGEN Repligen	+3.35%	+12.41%	+5.40%	+25.07%	+23.17%
TECH Bio-Techne	+0.03%	+0.10%	+0.25%	+0.55%	+21.72%
WAT Waters	+1.67%	+3.57%	+6.79%	+20.63%	+33.66%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BRKR Bruker	$54.76 -3.1%	$58.76	$32.37 ▼ $66.98	$8.34B	1.22	2.35 million shs	437,818 shs
RGEN Repligen	$174.95 -5.0%	$175.63	$100.99 ▼ $198.87	$9.87B	1.08	1.05 million shs	335,038 shs
TECH Bio-Techne	$72.48 -0.1%	$72.38	$43.19 ▼ $72.69	$11.37B	1.3	3.31 million shs	1.26 million shs
WAT Waters	$436.41 -1.7%	$420.24	$282.77 ▼ $454.54	$42.88B	1.15	959,935 shs	204,607 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BRKR Bruker	+1.69%	-2.38%	+1.42%	-2.90%	+56.19%
RGEN Repligen	+3.35%	+12.41%	+5.40%	+25.07%	+23.17%
TECH Bio-Techne	+0.03%	+0.10%	+0.25%	+0.55%	+21.72%
WAT Waters	+1.67%	+3.57%	+6.79%	+20.63%	+33.66%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BRKR Bruker	2.57	Moderate Buy	$59.43	5.11% Upside
RGEN Repligen	2.89	Moderate Buy	$173.21	-5.95% Downside
TECH Bio-Techne	2.12	Hold	$68.92	-4.96% Downside
WAT Waters	2.79	Moderate Buy	$443.79	-0.25% Downside

Current Analyst Ratings Breakdown

Latest WAT, BRKR, RGEN, and TECH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/14/2026	BRKR Bruker	JPMorgan Chase & Co. Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Overweight ➝ Neutral	$60.00
10/13/2026	WAT Waters	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$475.00 ➝ $515.00
10/13/2026	BRKR Bruker	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Hold	$60.00 ➝ $62.00
10/8/2026	RGEN Repligen	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C-) ➝ Hold (C)
10/8/2026	WAT Waters	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C-) ➝ Hold (C)
10/7/2026	WAT Waters	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Overweight	$460.00 ➝ $500.00
10/7/2026	RGEN Repligen	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Overweight	$175.00 ➝ $225.00
10/7/2026	BRKR Bruker	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Overweight	$58.00 ➝ $70.00
10/1/2026	WAT Waters	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$440.00 ➝ $490.00
10/1/2026	BRKR Bruker	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$70.00 ➝ $72.00
9/29/2026	RGEN Repligen	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy

(Data available from 10/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BRKR Bruker	$3.44B	2.51	$3.43 per share	16.47	$16.28 per share	3.47
RGEN Repligen	$785.10M	13.24	$3.53 per share	52.15	$37.42 per share	4.92
TECH Bio-Techne	$1.22B	9.36	$2.35 per share	30.88	$13.47 per share	5.38
WAT Waters	$4.64B	9.41	$16.94 per share	26.26	$43.01 per share	10.34

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BRKR Bruker	-$8.60M	-$0.70	N/A	23.27	1.70	-2.35%	12.47%	4.91%	11/2/2026 (Estimated)
RGEN Repligen	$48.89M	$0.73	252.29	71.11	3.25	5.29%	5.30%	3.79%	10/27/2026 (Estimated)
TECH Bio-Techne	$181.86M	$1.15	42.15	36.44	8.78	14.97%	13.23%	10.61%	11/4/2026 (Estimated)
WAT Waters	$642.63M	$4.01	110.95	26.98	2.54	3.58%	11.27%	6.73%	11/3/2026 (Estimated)

Latest WAT, BRKR, RGEN, and TECH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/4/2026	Q1 2027	TECH Bio-Techne	$0.4433	N/A	N/A	N/A	$292.61 million	N/A
11/3/2026	Q3 2026	WAT Waters	$4.00	N/A	N/A	N/A	$1.75 billion	N/A
11/2/2026	Q3 2026	BRKR Bruker	$0.4188	N/A	N/A	N/A	$865.16 million	N/A
10/27/2026	Q3 2026	RGEN Repligen	$0.4628	N/A	N/A	N/A	$206.70 million	N/A
8/12/2026	Q4 2026	TECH Bio-Techne	$0.5190	$0.52	+$0.0010	$0.35	$314.63 million	$321.19 million
8/4/2026	Q2 2026	BRKR Bruker	$0.3849	$0.49	+$0.1051	-$0.41	$853.57 million	$838.50 million
8/4/2026	Q2 2026	WAT Waters	$3.01	$3.05	+$0.04	-$1.39	$1.62 billion	$1.65 billion
7/28/2026	Q2 2026	RGEN Repligen	$0.4470	$0.54	+$0.0930	$0.09	$201.59 million	$204.13 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BRKR Bruker	$0.20	0.35%	+4.56%	N/A	N/A
RGEN Repligen	N/A	N/A	N/A	N/A	N/A
TECH Bio-Techne	$0.32	0.44%	N/A	27.83%	N/A
WAT Waters	N/A	N/A	N/A	N/A	N/A

Latest WAT, BRKR, RGEN, and TECH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/14/2026	BRKR Bruker	quarterly	$0.05	0.32%	9/21/2026	9/21/2026	10/7/2026
8/12/2026	TECH Bio-Techne	quarterly	$0.65	0.44%	8/24/2026	8/24/2026	9/4/2026
8/12/2026	TECH Bio-Techne	quarterly	$0.08	0.44%	8/17/2026	8/17/2026	8/28/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BRKR Bruker	0.76	1.85	0.92
RGEN Repligen	0.26	9.05	7.64
TECH Bio-Techne	0.09	4.55	3.35
WAT Waters	0.32	1.86	1.29

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BRKR Bruker	79.52%
RGEN Repligen	97.64%
TECH Bio-Techne	98.95%
WAT Waters	94.01%

Insider Ownership

Company	Insider Ownership
BRKR Bruker	27.20%
RGEN Repligen	0.60%
TECH Bio-Techne	1.30%
WAT Waters	0.31%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BRKR Bruker	11,085	152.36 million	110.92 million	Optionable
RGEN Repligen	2,000	56.44 million	56.10 million	Optionable
TECH Bio-Techne	3,000	156.82 million	154.78 million	Optionable
WAT Waters	7,900	98.25 million	97.94 million	Optionable

WAT, BRKR, RGEN, and TECH Headlines

Recent News About These Companies

The Anxiety That Inspired Roger Waters To Write “Time” by Pink Floyd

October 16 at 2:56 AM | songfacts.comS

Roger Waters Criticizes Metallica's James Hetfield for His Political Comments

October 16 at 2:56 AM | msn.com

Waters plans PH return for pickleball showcase

October 16 at 2:56 AM | msn.com

Roger Waters Rips ‘Prick’ James Hetfield Over Apolitical Stance

October 16 at 2:56 AM | ultimateclassicrock.comU

Anna Leigh Waters' net worth and endorsements: Is she the richest pickleball star?

October 15 at 11:51 AM | tuko.co.keT

Fundraising Update: Representative James P. McGovern just disclosed $118.1K of new fundraising

October 15 at 10:30 AM | quiverquant.comQ

Waters rallies support as rivals circle

October 15 at 6:50 AM | politico.comP

Waters Launches AI Link Software to Automate Lab Workflows

October 14 at 12:38 PM | finance.yahoo.com

Democrats face clash over Maxine Waters

October 14 at 12:38 PM | politico.comP

Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release

October 13 at 8:00 AM | prnewswire.com

Edward Waters announces it will build first on-campus dorm since 1982

October 12, 2026 | msn.com

Healing waters: 10 of the best spa towns in Europe for a restorative autumn break

October 12, 2026 | theguardian.com

IER Comment on: Updated Definition of ‘‘Waters of the United States’’

October 11, 2026 | instituteforenergyresearch.orgI

Eight sham bands Roger Waters can’t stand: “I am far, far, far more improtant”

October 10, 2026 | faroutmagazine.co.ukF

Waters (NYSE:WAT) Stock Rating Raised to "Buy" at Wall Street Zen

October 10, 2026 | americanbankingnews.com

Waters (NYSE:WAT) Raised to "Buy" at Wall Street Zen

October 10, 2026 | marketbeat.com

5 Songs That Prove Roger Waters Was the Driving Force Behind Pink Floyd

October 9, 2026 | americansongwriter.comA

Roger Waters regrets letting Roy Harper sing on 'Wish You Were Here'

October 8, 2026 | msn.com

The “heavy-handed” 1980s Pink Floyd album Roger Waters wishes he could change: “A bit clunky”

October 8, 2026 | faroutmagazine.co.ukF

Here's Why You Should Retain WAT Stock in Your Portfolio for Now

October 8, 2026 | zacks.com

Representative Maxine Waters introduces H.R. 10640: Urban Health Transformation Act of 2026

October 6, 2026 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

WAT, BRKR, RGEN, and TECH Company Descriptions

Bruker NASDAQ:BRKR

$54.76 -1.78 (-3.15%)

As of 12:07 PM Eastern

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Repligen NASDAQ:RGEN

$174.95 -9.22 (-5.01%)

As of 12:07 PM Eastern

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Bio-Techne NASDAQ:TECH

$72.47 -0.05 (-0.06%)

As of 12:07 PM Eastern

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Waters NYSE:WAT

$436.41 -7.74 (-1.74%)

As of 12:07 PM Eastern

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest WAT, BRKR, RGEN, and TECH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest WAT, BRKR, RGEN, and TECH Earnings

Compare Dividends

Latest WAT, BRKR, RGEN, and TECH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

WAT, BRKR, RGEN, and TECH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

WAT, BRKR, RGEN, and TECH Company Descriptions

Bruker NASDAQ:BRKR

Repligen NASDAQ:RGEN

Bio-Techne NASDAQ:TECH

Waters NYSE:WAT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools